Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|May 13, 1998

Vitrea sparks Vital Images results

Sales of its Vitrea 3-D visualization workstation helped Vital Images report sharply higher revenues for its first quarter (end-March), although the company’s net loss grew as well. For the period, the Minneapolis company posted sales of $766,000,

Sales of its Vitrea 3-D visualization workstation helped Vital Images report sharply higher revenues for its first quarter (end-March), although the company’s net loss grew as well. For the period, the Minneapolis company posted sales of $766,000, compared with revenues of $156,000 in the first quarter of 1997. Vitrea began shipping in October, and in the most recent period contributed $488,000 to Vital Images’ revenues.

The company’s net loss for the first quarter was $1.1 million, compared with a net loss of $873,000 for the first quarter of 1997. The net loss for the most recent period included a charge of $180,000 in connection with the departure of Vital Images’ former CEO, Andrew Weiss (SCAN 2/18/98).

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.